AI assistant
Cemindia Projects Limited — Major Shareholding Notification 2025
Apr 16, 2025
61981_rns_2025-04-16_d393852c-a522-4baf-ba34-5e7084acbace.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Docusign Envelope ID: E6308044-0DF4-4B8E-A30D-24289AE8AAD7
MASSACHUSETTS INSTITUTE OF TECHNOLOGY P: 617-253-4900 INVESTMENT MANAGEMENT COMPANY F: 617-258-6676 One Broadway, 9[th] Floor, Suite 200 www.mitimco.org Cambridge, MA 02142
15 April 2025
The Secretary The Secretary BSE Limited National Stock Exchange of India Phiroze Jeejeebhoy Towers Limited Dalal Street, Fort Exchange Plaza, 3[rd] Floor Mumbai - 400001 Plot No.3-1”G” Block, I.F.B. Centre, E-mail: [email protected] Bandra-Kurla-Complex, Bandra (East) Mumbai – 400 051 Email: [email protected]
The Compliance Officer
ITD Cementation India Limited 9th Floor, Prima Bay, Tower B, Gate No. 5, Saki Vihar Road, Powai, Mumbai - 400072 E-mail: [email protected]; [email protected]
BY E-MAIL
Dear Sirs
Subject: Disclosure under Regulation 29 (2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations 2011 (“Takeover Regulations”)
This is to inform you that Massachusetts Institute of Technology (“ MIT ”) and 238 Plan Associates LLC (“ 238 Plan ”) have sold an aggregate of 4,640,700 and 1,567,900 equity shares of ITD Cementation India Limited, respectively, which coupled with previous transactions by MIT and 238 Plan has cumulatively crossed the 2% threshold for the purpose of Regulation 29(2) of the Takeover Regulations.
Accordingly, please find enclosed a disclosure under Regulation 29(2) of the Takeover Regulations.
Kindly take the above on record.
Thanking you
Yours faithfully
For MASSACHUSETTS INSTITUTE OF For 238 PLAN ASSOCIATES TECHNOLOGY LLC ____ ______ Seth Alexander Seth Alexander President, MIT Investment Management Company, President, Authorized Signatory Authorized Signatory Encl: As above
Docusign Envelope ID: E6308044-0DF4-4B8E-A30D-24289AE8AAD7
Docusign Envelope ID: E6308044-0DF4-4B8E-A30D-24289AE8AAD7
Disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
| Name of the Target Company (“TC”) | Name of the Target Company (“TC”) | Name of the Target Company (“TC”) | Name of the Target Company (“TC”) | Name of the Target Company (“TC”) | Name of the Target Company (“TC”) | Name of the Target Company (“TC”) | Name of the Target Company (“TC”) | |||
|---|---|---|---|---|---|---|---|---|---|---|
| ITD Cementation India Limited | ||||||||||
| Name(s) of the Acting in Concert |
~~acquirer~~/ seller and Persons | Sellers | ||||||||
| (PAC) with the acquirer | 1. Massachusetts Institute of Technology | |||||||||
| (“MIT”) | ||||||||||
| 2. 238 Plan Associates LLC(“238 Plan”) | ||||||||||
| Whether the~~acquirer~~/ seller belongs to Promoter/Promotergroup |
~~acquirer~~/ seller belongs to | |||||||||
| No | ||||||||||
| Name(s) of the Stock Exchange(s) where the shares of TC are Listed |
The National Stock Exchange of India Limited | |||||||||
| BSE Limited | ||||||||||
| Details of the | ~~acquisition~~/ disposal as follows | Number | % w.r.t. total | % w.r.t. total | ||||||
| share / voting | diluted share | |||||||||
| capital | / voting |
|||||||||
| wherever | capital of the | |||||||||
| applicable (*) | TC (**) | |||||||||
| Before the **consideration, ** |
~~acquisition~~ ~~/~~ disposal under |
|||||||||
| holding of: | ||||||||||
| a) Shares carrying voting rights | ||||||||||
| (i) MIT |
||||||||||
| 5,073,000 | 2.95% | 2.95% | ||||||||
| (ii) 238 Plan |
||||||||||
| 1,721,000 | 1.00% | 1.00% | ||||||||
| b) Shares in the nature of encumbrance (pledge/ lien / non-disposal undertaking / others) |
||||||||||
| NA | NA | NA | ||||||||
| c) Voting rights (VR) otherwise than by shares | NA | NA | NA | |||||||
| d) Warrants / convertible securities / any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) |
||||||||||
| NA | NA | NA | ||||||||
| e) Total(a+b+c+d) | 6,794,000 | 3.95% | 3.95% | |||||||
| Details of | ~~acquisition /~~sale | |||||||||
| a) Shares carrying voting rights | ||||||||||
| ~~acquired /~~sold | ||||||||||
| (i) | 4,640,700(1) | 2.70%(1) | 2.70%(1) | |||||||
| MIT | ||||||||||
| (ii) | 1,567,900(1) | 0.91%(1) | 0.91%(1) | |||||||
| 238 Plan | ||||||||||
| b) VRs | ~~acquired~~/ sold otherwise than by shares | NA | NA | NA | ||||||
| c) Warrants / convertible securities / any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) acquired / sold |
||||||||||
| NA | NA | NA | ||||||||
| d) Shares encumbered / invoked / released by the acquirer |
||||||||||
| NA | NA | NA | ||||||||
1 | 3
Docusign Envelope ID: E6308044-0DF4-4B8E-A30D-24289AE8AAD7
| e) Total | e) Total | ||||||
|---|---|---|---|---|---|---|---|
| (a+b+c+/-d) | 6,208,600 | 3.61% | 3.61% | ||||
| After the | |||||||
| ~~acquisition /~~sale, holding of: | |||||||
| a) Shares carrying voting rights | |||||||
| (i) MIT |
|||||||
| 432,300 | 0.25% | 0.25% | |||||
| (ii) 238 Plan |
|||||||
| 153,100 | 0.09% | 0.09% | |||||
| b) Shares encumbered with the acquirer | |||||||
| NA | NA | NA | |||||
| c) VRs otherwise than by shares | |||||||
| NA | NA | NA | |||||
| d) Warrants / convertible securities / any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) after acquisition |
|||||||
| NA | NA | NA | |||||
| e) Total (a+b+c+d) | |||||||
| 5,85,400 | 0.34% | 0.34% | |||||
| Mode of~~acquisition~~/ sale (e.g. open market / off- market / public issue / rights issue / preferential allotment / inter-se transfer etc). |
|||||||
| ~~acquisition~~/ sale (e.g. open market / off- | |||||||
Off-market (shares tendered in open offer) + |
|||||||
open market |
|||||||
| Date of~~acquisition~~/ sale of shares / VR or date of receipt of intimation of allotment of shares, whichever is applicable |
|||||||
| ~~acquisition~~/ sale of shares / VR or date of | |||||||
Various sales between 12 June 2024 and 11 |
|||||||
| of intimation of allotment of shares, | |||||||
April 2025. |
|||||||
| Equity share capital / total voting capital of the TC before the said~~acquisition~~/ sale |
|||||||
171,787,584 equity shares of face value INR 1 |
|||||||
| ~~acquisition~~/ sale | each, amounting to INR 17,17,87,584 | ||||||
| Equity share capital / total voting capital of the TC after the said~~acquisition~~/ sale |
|||||||
17,17,87,584 equity shares of face value INR 1 |
|||||||
| ~~acquisition~~/ sale | each, amounting to INR 17,17,87,584 | ||||||
| Total diluted the said sale |
|||||||
| share / voting capital of the TC after | 17,17,87,584 equity shares of face value INR 1 |
||||||
| each, amounting to INR 17,17,87,584 | |||||||
Endnote:
([1] ) MIT has sold an aggregate of 4,640,700 equity shares of the Target Company, comprising of: (i) 4,565,700 equity shares tendered in the open offer (for which consideration was received on 9 April 2024) and (ii) 75,000 equity shares sold in the open market, and 238 Plan has sold an aggregate of 1,567,900 equity shares of the Target Company, comprising of: (i) 1,548,900 equity shares tendered in the open offer (for which consideration was received on 9 April 2024) and (ii) 19,000 equity shares sold in the open market.
(*) Total share capital / voting capital to be taken as per the latest filing done by the Target Company to the Stock Exchange under Regulation 31 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
(**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.
[ Signature page follows ]
2 | 3
Docusign Envelope ID: E6308044-0DF4-4B8E-A30D-24289AE8AAD7
For MASSACHUSETTS INSTITUTE OF TECHNOLOGY
________
For 238 PLAN ASSOCIATES LLC
==> picture [163 x 37] intentionally omitted <==
________
Seth Alexander
President, MIT Investment Management Company, Authorized Signatory
Seth Alexander
President, Authorized Signatory
Place : Cambridge, MA USA Date : 15 April 2025
3 | 3